Stock Report Halozyme Therapeutics Inc. with In-Depth Stock Analysis

Halozyme Therapeutics Inc. XNAS: HALO

Mid-range Performer

55.64 -0.43 (-0.77%)

30.46% Gain from 52W Low

1.9M XNAS Volume

XNAS 02 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Halozyme Therapeutics Inc. is on 09 Jun 2025 for the purpose of Goldman Sachs 46th Annual Global Healthcare Conference 2025 See details

30.46% Gain from 52W Low

Detailed Stock Analysis for Halozyme Therapeutics Inc. with Real-time Stock Report